Literature DB >> 16452208

Aberrant activation of notch signaling in human breast cancer.

Spyros Stylianou1, Rob B Clarke, Keith Brennan.   

Abstract

A role for Notch signaling in human breast cancer has been suggested by both the development of adenocarcinomas in the murine mammary gland following pathway activation and the loss of Numb expression, a negative regulator of the Notch pathway, in a large proportion of breast carcinomas. However, it is not clear currently whether Notch signaling is frequently activated in breast tumors, and how it causes cellular transformation. Here, we show accumulation of the intracellular domain of Notch1 and hence increased Notch signaling in a wide variety of human breast carcinomas. In addition, we show that increased RBP-Jkappa-dependent Notch signaling is sufficient to transform normal breast epithelial cells and that the mechanism of transformation is most likely through the suppression of apoptosis. More significantly, we show that attenuation of Notch signaling reverts the transformed phenotype of human breast cancer cell lines, suggesting that inhibition of Notch signaling may be a therapeutic strategy for this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452208     DOI: 10.1158/0008-5472.CAN-05-3054

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  242 in total

1.  Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.

Authors:  Sungpil Cho; Meiling Lu; Xiaolong He; Pui-Lai Rachel Ee; Uppoor Bhat; Erasmus Schneider; Lucio Miele; William T Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.

Authors:  Mohammad Mahdi Forghanifard; Shaghayegh Taleb; Mohammad Reza Abbaszadegan
Journal:  Pathol Oncol Res       Date:  2014-11-01       Impact factor: 3.201

3.  Endocytosis by Numb breaks Notch symmetry at cytokinesis.

Authors:  Lydie Couturier; Nicolas Vodovar; François Schweisguth
Journal:  Nat Cell Biol       Date:  2012-01-22       Impact factor: 28.824

4.  ErbB2 induces Notch1 activity and function in breast cancer cells.

Authors:  Jaime Lindsay; Xuanmao Jiao; Toshiyuki Sakamaki; Mathew C Casimiro; Lawrence A Shirley; Thai H Tran; Xiaoming Ju; Manran Liu; Zhiping Li; Chenguang Wang; Sanjay Katiyar; Mahadev Rao; Kathleen G Allen; Robert I Glazer; Changhui Ge; Pamela Stanley; Michael P Lisanti; Hallgeir Rui; Richard G Pestell
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 5.  Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

Authors:  Casper Groth; Mark E Fortini
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

6.  Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.

Authors:  Xiang Jiao; Laura D Wood; Monica Lindman; Sian Jones; Phillip Buckhaults; Kornelia Polyak; Saraswati Sukumar; Hannah Carter; Dewey Kim; Rachel Karchin; Tobias Sjöblom
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

7.  Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest.

Authors:  Lauren J Manderfield; Haig Aghajanian; Kurt A Engleka; Lillian Y Lim; Feiyan Liu; Rajan Jain; Li Li; Eric N Olson; Jonathan A Epstein
Journal:  Development       Date:  2015-08-07       Impact factor: 6.868

8.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

Review 9.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

10.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.